| Financial Year |
March 31 2023 |
| Monetary Funds |
2,822,735,743.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
358,675.00 |
| Accounts Receivable |
1,285,656,748.81 |
| Advances to Suppliers |
168,809,601.04 |
| Other Receivables |
33,316,819.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,152,027,509.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,070,736.55 |
| Total Current Assets |
5,656,077,028.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
28,023,225.69 |
| Long-term Equity Investment |
-- |
| Investment Properties |
28,379,233.27 |
| Fixed Assetes |
800,532,741.73 |
| Under-construction Projects |
25,396,826.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
395,596,581.84 |
| R&D expenses |
103,613,887.28 |
| Goodwill |
728,181,224.29 |
| Long-Term Deferred and Prepaid Expenses |
15,671,077.15 |
| Deferred Income Tax Assets |
152,196,632.07 |
| Other Non-Current Assets |
6,630,234.84 |
| Sub-Total of Non-Current Assets |
2,388,199,269.11 |
| Total Assets |
8,044,276,298.01 |
| Short-Term Loans |
54,760,813.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,954,122.97 |
| Accounts Payable |
292,682,510.76 |
| Accounts Received In Advance |
128,073.13 |
| Employee Compensation Payable |
115,350,564.98 |
| Taxes Payable |
132,615,539.25 |
| Interest Payable |
1,454,972.36 |
| Dividend Payable |
190,000,000.00 |
| Other payables |
323,013,087.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,949,154.34 |
| Other Current Liabilities |
16,512,325.21 |
| Sub-Total of Current Liabilities |
1,370,270,186.07 |
| Long-term Loans |
97,110,161.29 |
| Bonds Payable |
653,666,547.25 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
66,519,105.43 |
| Deferred Income Tax Liabilities |
18,007,985.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
917,118,883.18 |
| Total Liabilities |
2,287,389,069.25 |
| Paid-In Capital(Or Share Stock) |
514,296,856.00 |
| Capital Surplus |
294,398,560.75 |
| Surplus Reserve |
228,578,647.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,679,792,324.32 |
| Minority Stockholder's Interest |
889,136,212.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,867,751,016.40 |
| Owner's Equity（Stockholder's Equity） |
5,756,887,228.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,044,276,298.01 |
